Evidence map›Paper›PMID 29616393›Full record

ArticleInternational journal of clinical pharmacy2018

Overview of pharmacovigilance practices at the largest academic healthcare system in the State of Qatar.

Moza Al Hail, Wessam Elkassem, Anas Hamad, Pallivalappila Abdulrouf, Binny Thomas, Derek Stewart

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Overview of this issue: pharmacovigilance, what is new?International journal of clinical pharmacy · 2018
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Moza Al HailHamad Medical Corporation, 3050, Doha, Qatar.
Wessam ElkassemHamad Medical Corporation, 3050, Doha, Qatar.
Anas HamadHamad Medical Corporation, 3050, Doha, Qatar.
Pallivalappila AbdulroufHamad Medical Corporation, 3050, Doha, Qatar.
Binny ThomasHamad Medical Corporation, 3050, Doha, Qatar. BThomas28@hamad.qa.ORCID http://orcid.org/0000-0003-1065-8343
Derek StewartRobert Gordon University, Aberdeen, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adverse Drug Reactions (ADRs) are major global concern, adversely impacting patient safety and health outcomes. ADRs cause significant morbidity and mortality among hospitalised patients, causing greater length of hospital stay, increased healthcare costs and patient dissatisfaction to the treatments. Pharmacovigilance (PV), a process of detecting, monitoring and preventing drug-related harm, plays a vital role to ensure patient safety. ADR reporting is the cornerstone of PV. PV practices in Qatar are relatively new and are evolving rapidly. The purpose of this article is to explore the medication safety practices (notably ADR reporting) at the largest academic healthcare center in Qatar. The article further provides evidence on how information related to ADRs are generated and interpreted. Furthermore, it describes how a designated center for monitoring medication safety activities was established at the largest healthcare provider in Qatar.

Indexed as

PharmacovigilanceAcademic Medical CentersAdverse Drug Reaction Reporting SystemsDelivery of Health CareDrug-Related Side Effects and Adverse ReactionsHumansPatient SafetyProgram DevelopmentProgram EvaluationQatarRisk AssessmentRisk FactorsAdverse Drug ReactionsHamad Medical CorporationMedication safetyPharmacovigilanceQatar

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.